These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
|
N/A
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of Each Class
|
|
Trading Symbol(s)
|
|
Name of Each Exchange on Which Registered
|
|
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
|
☒
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
||
|
Page
|
|
|
EXPLANATORY NOTE
|
|
|
PART I - FINANCIAL INFORMATION
|
|
|
Item 1. Financial Statements
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 4. Controls and Procedures
|
|
|
PART II - OTHER INFORMATION
|
|
|
Item 1. Legal Proceedings
|
|
|
Item 1A. Risk Factors
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
Item 3. Defaults Upon Senior Securities
|
|
|
Item 4. Mine Safety Disclosures
|
|
|
Item 5. Other Information
|
|
|
Item 6. Exhibits
|
|
|
Signatures
|
|
Page
|
|
|
Condensed Consolidated Balance Sheets as of
March 31, 2025
and
December 31, 2024
|
|
|
Condensed Consolidated Statements of Operations for the
three months ended
March 31, 2025
and
March 31, 2024
|
|
|
Condensed Consolidated Statements of
Comprehensive Income
for the
three months ended
March 31, 2025
and
March 31, 2024
|
|
|
Condensed Consolidated Statements of Cash Flows for the
three months ended
March 31, 2025
and
March 31, 2024
|
|
|
Condensed Consolidated Statements of Changes in Equity for the
three months ended
March 31, 2025
and
March 31,
2024
|
|
|
Notes to the Condensed Consolidated Financial Statements
|
|
March 31,
2025
|
December 31,
2024
|
||
|
Assets
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents (amounts related to consolidated variable interest entities of
$
$
|
$
|
$
|
|
|
Accounts receivable, net (amounts related to consolidated variable interest entities of
$
$
|
|
|
|
|
Inventories
|
|
|
|
|
Other current assets
|
|
|
|
|
Total current assets
|
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
Goodwill
|
|
|
|
|
Intangibles, net
|
|
|
|
|
Prepaid pension asset
|
|
|
|
|
Other non-current assets (amounts related to consolidated variable interest entities of
$
$
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities and Equity
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$
|
$
|
|
|
Accrued compensation and benefits
|
|
|
|
|
Current portion of debt
|
|
|
|
|
Other current liabilities
|
|
|
|
|
Total current liabilities
|
|
|
|
|
Non-current debt due after one year (amounts related to consolidated variable interest entities of
$
million
and
$
|
|
|
|
|
Deferred tax liabilities
|
|
|
|
|
Pension liabilities and other postretirement benefits, net of current portion
|
|
|
|
|
Other non-current liabilities (amounts related to consolidated variable interest entities of
$
and
$
|
|
|
|
|
Total liabilities
|
|
|
|
|
Commitments and Contingencies (Note 15)
|
|
|
|
|
Equity:
|
|||
|
Preferred stock;
$
|
|
|
|
|
Common stock;
$
shares outstanding at
March 31, 2025
and
December 31, 2024
, respectively
|
|
|
|
|
Deferred shares;
€
|
|
|
|
|
Treasury stock; at cost;
2024
, respectively
|
(
|
(
|
|
|
Capital in excess of par value
|
|
|
|
|
Accumulated other comprehensive loss
|
(
|
(
|
|
|
Retained earnings
|
|
|
|
|
Total shareholders’ equity
|
|
|
|
|
Noncontrolling interests
|
|
|
|
|
Total equity
|
|
|
|
|
Total liabilities and equity
|
$
|
$
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Net sales
|
$
|
$
|
|
|
Cost of goods sold
|
(
|
(
|
|
|
Gross profit
|
|
|
|
|
Selling, general and administrative expenses
|
(
|
(
|
|
|
Transaction and integration-related expenses associated with the Combination
|
(
|
(
|
|
|
Operating profit
|
|
|
|
|
Pension and other postretirement non-service income (expense), net
|
|
(
|
|
|
Interest expense, net
|
(
|
(
|
|
|
Other expense, net
|
(
|
(
|
|
|
Income before income taxes
|
|
|
|
|
Income tax expense
|
(
|
(
|
|
|
Net income
|
|
|
|
|
Net loss attributable to noncontrolling interests
|
|
|
|
|
Net income attributable to common shareholders
|
$
|
$
|
|
|
Basic earnings per share attributable to common shareholders
|
$
|
$
|
|
|
Diluted earnings per share attributable to common shareholders
|
$
|
$
|
|
|
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
|
|||
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Net income
|
$
|
$
|
|
|
Other comprehensive income (loss), net of tax:
|
|||
|
Foreign currency translation gain (loss)
|
|
(
|
|
|
Defined benefit pension and other postretirement benefit plans adjustments
|
(
|
|
|
|
Net gain (loss) on cash flow hedging derivatives
|
|
(
|
|
|
Other comprehensive income (loss), net of tax
|
|
(
|
|
|
Comprehensive income
|
|
|
|
|
Comprehensive loss attributable to noncontrolling interests
|
|
|
|
|
Comprehensive income attributable to common shareholders
|
$
|
$
|
|
|
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
|
|||
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Operating activities:
|
|||
|
Net income
|
$
|
$
|
|
|
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
|
|||
|
Depreciation, depletion and amortization
|
|
|
|
|
Cash surrender value increase in excess of premiums paid
|
(
|
|
|
|
Share-based compensation expense
|
|
|
|
|
Deferred income tax benefit
|
(
|
(
|
|
|
Pension and other postretirement funding more than cost
|
(
|
(
|
|
|
Other
|
|
|
|
|
Change in operating assets and liabilities, net of acquisitions and divestitures:
|
|||
|
Accounts receivable
|
(
|
(
|
|
|
Inventories
|
(
|
|
|
|
Other assets
|
(
|
(
|
|
|
Accounts payable
|
(
|
(
|
|
|
Income taxes
|
(
|
|
|
|
Accrued liabilities and other
|
(
|
(
|
|
|
Net cash provided by operating activities
|
|
|
|
|
Investing activities:
|
|||
|
Capital expenditures
|
(
|
(
|
|
|
Cash paid for purchase of businesses, net of cash acquired
|
(
|
|
|
|
Other
|
|
|
|
|
Net cash used for investing activities
|
(
|
(
|
|
|
Financing activities:
|
|||
|
Additions to debt
|
|
|
|
|
Repayments of debt
|
(
|
(
|
|
|
Debt issuance costs
|
(
|
|
|
|
Changes in commercial paper, net
|
|
|
|
|
Other debt repayments, net
|
(
|
|
|
|
Repayments of finance lease liabilities
|
(
|
(
|
|
|
Tax paid in connection with shares withheld from employees
|
(
|
|
|
|
Purchases of treasury stock
|
|
(
|
|
|
Cash dividends paid to shareholders
|
(
|
|
|
|
Other
|
|
|
|
|
Net cash provided by financing activities
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(
|
|
|
Decrease in cash and cash equivalents
|
(
|
(
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
Cash and cash equivalents at end of period
|
$
|
$
|
|
|
Shares of
Common Stock
|
Common Stock
|
Capital in
Excess of Par
Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest (“NCI”)
|
Total
|
|
|
Balance at
December 31, 2024
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income
|
—
|
—
|
—
|
—
|
|
—
|
|
(
|
|
|
Other comprehensive income, net of tax
|
—
|
—
|
—
|
—
|
—
|
|
|
—
|
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Shares distributed by Smurfit Kappa Employee
Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Issuance of common stock net of tax paid in
connection with shares withheld from employees
|
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Cancellation of deferred shares by Smurfit Kappa
Employee Trust
|
—
|
—
|
—
|
|
(
|
—
|
|
—
|
|
|
Dividends declared (
$
|
—
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at March 31, 2025
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Shares of
Common Stock
|
Common Stock
|
Capital in
Excess of Par
Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest (“NCI”)
|
Total
|
|
|
Balance at
December 31, 2023
(1)
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income
|
—
|
—
|
—
|
—
|
|
—
|
|
—
|
|
|
Other comprehensive loss, net of tax
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
—
|
(
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Shares distributed by Smurfit Kappa Employee
Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Purchases of treasury stock
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|
Issuance of common stock
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Balance at March 31, 2024
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Three months ended
|
|
|
March 31, 2024
|
|
|
Net sales
|
$
|
|
Net income attributable to common shareholders
|
|
|
Three months ended March 31, 2025
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
$
|
$
|
$
|
$
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
$
(
|
$
(
|
$
(
|
||||
|
Segment selling, general and administrative expenses
|
(
|
(
|
(
|
||||
|
$
(
|
$
(
|
$
(
|
$
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service income, net
|
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
(
|
||||||
|
Income before income taxes
|
$
|
|
Three months ended March 31, 2024
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
$
|
$
|
$
|
$
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
$
(
|
$
(
|
$
(
|
||||
|
Segment selling, general and administrative expenses
|
(
|
(
|
(
|
||||
|
$
(
|
$
(
|
$
(
|
$
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service expense, net
|
(
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
|
||||||
|
Income before income taxes
|
$
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Capital expenditures:
|
|||
|
North America
|
$
|
$
|
|
|
Europe, MEA and APAC
|
|
|
|
|
LATAM
|
|
|
|
|
Total reportable segments
|
$
|
$
|
|
|
Corporate
|
|
|
|
|
Total capital expenditures
|
$
|
$
|
|
|
March 31,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Assets:
|
|||
|
North America
|
$
|
$
|
|
|
Europe, MEA and APAC
|
|
|
|
|
LATAM
|
|
|
|
|
Total reportable segments
|
$
|
$
|
|
|
Corporate
(1)
|
|
|
|
|
Total assets
|
$
|
$
|
|
Three months ended March 31, 2025
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Three months ended March 31, 2024
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Contract
Assets
(Short-Term)
|
Contract
Liabilities
(Short-Term)
|
||
|
Beginning balance - January 1, 2025
|
$
|
$
|
|
|
Decrease
|
(
|
(
|
|
|
Ending balance - March 31, 2025
|
$
|
$
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Transaction-related costs associated with the Combination
|
$
(
|
$
(
|
|
|
Integration-related costs associated with the Combination
|
(
|
|
|
|
Total transaction and integration-related costs associated with the Combination
|
$
(
|
$
(
|
|
|
March 31,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Gross accounts receivable
|
$
|
$
|
|
|
Less: Allowances
|
(
|
(
|
|
|
Accounts receivable, net
|
$
|
$
|
|
March 31,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Finished goods
|
$
|
$
|
|
|
Work-in-progress
|
|
|
|
|
Raw materials
|
|
|
|
|
Consumables and spare parts
|
|
|
|
|
Inventories
|
$
|
$
|
|
March 31,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Land and buildings
|
$
|
$
|
|
|
Plant and equipment
|
|
|
|
|
Construction in progress
|
|
|
|
|
Finance lease right-of-use assets
|
|
|
|
|
Property, plant and equipment at cost, excluding forestlands
|
|
|
|
|
Less: Accumulated depreciation and amortization
|
(
|
(
|
|
|
Property, plant and equipment, net, excluding forestlands
|
$
|
$
|
|
|
Forestlands, net of depletion
|
|
|
|
|
Property, plant and equipment, net
|
$
|
$
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Interest expense
|
$
(
|
$
(
|
|
|
Interest income
|
|
|
|
|
Interest expense, net
|
$
(
|
$
(
|
|
|
March 31, 2025
|
December 31, 2024
|
||||||
|
Book Value
|
Fair Value
|
Book Value
|
Fair Value
|
||||
|
Debt with fixed interest rates
|
$
|
$
|
$
|
$
|
|||
|
Level 1
|
Level 2
|
||||||
|
March 31,
|
December 31,
|
March 31,
|
December 31,
|
||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Assets
|
|||||||
|
Other Investments:
|
|||||||
|
Listed
|
$
|
$
|
$
|
$
|
|||
|
Unlisted
|
|
|
|
|
|||
|
Derivatives in cash flow hedging relationships
|
|
|
|
|
|||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|||
|
Assets measured at fair value
|
$
|
$
|
$
|
$
|
|||
|
Liabilities
|
|||||||
|
Derivatives in cash flow hedging relationships
|
$
|
$
|
$
|
$
|
|||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|||
|
Liabilities measured at fair value
|
$
|
$
|
$
|
$
|
|||
|
Receivable from financial institutions at December 31, 2024
|
$
|
|
Receivables sold to the financial institutions and derecognized
|
(
|
|
Receivables collected by financial institutions
|
|
|
Cash payments to financial institutions
|
(
|
|
Receivable from financial institutions at March 31, 2025
|
$
|
|
|
March 31,
|
December 31,
|
|
|
2025
|
2024
|
||
|
$
|
$
|
$
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
Commercial paper
|
|
|
|
|
Vendor financing and commercial card programs
|
|
|
|
|
Term loan facilities
|
|
|
|
|
Bank loans
|
|
|
|
|
Finance lease obligations
|
|
|
|
|
Bank overdrafts
|
|
|
|
|
Total debt, excluding debt issuance costs
|
|
|
|
|
Debt issuance costs
|
(
|
(
|
|
|
Total debt
|
|
|
|
|
Less: Current portion of debt
|
(
|
(
|
|
|
Non-current debt due after one year
|
$
|
$
|
|
Defined Benefit Pension Plans
|
|||||||
|
U.S. Plans
|
Non-U.S. Plans
|
||||||
|
Three months ended March 31,
|
Three months ended March 31,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Service cost
|
$
|
$
|
$
|
$
|
|||
|
Interest cost
|
|
|
|
|
|||
|
Expected return on assets
|
(
|
(
|
(
|
(
|
|||
|
Amortization of:
|
|||||||
|
Net actuarial loss
|
|
|
|
|
|||
|
Prior service credit
|
|
|
(
|
|
|||
|
Net periodic benefit (income) cost
|
$
(
|
$
|
$
|
$
|
|||
|
Other Postretirement Benefit Plans
|
|||
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Service cost
|
$
|
$
|
|
|
Interest cost
|
|
|
|
|
Net periodic benefit cost
|
$
|
$
|
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Defined Benefit Pension Plans Contributions
|
$
|
$
|
|
|
Other Postretirement Benefit Plans Contributions
|
|
|
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Numerator:
|
|||
|
Net income attributable to common shareholders
|
$
|
$
|
|
|
Denominator:
|
|||
|
Basic weighted average shares outstanding
|
|
|
|
|
Effect of dilutive share options
|
|
|
|
|
Diluted weighted average shares outstanding
|
|
|
|
|
Basic earnings per share attributable to common shareholders
|
$
|
$
|
|
|
Diluted earnings per share attributable to common shareholders
|
$
|
$
|
|
|
March 31,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Assets
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents
|
$
|
$
|
|
|
Accounts receivable
|
|
|
|
|
Non-current assets:
|
|||
|
Property, plant and equipment, net
|
|
|
|
|
Other non-current assets
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$
|
$
|
|
|
Current portion of debt
|
|
|
|
|
Other current liabilities
|
|
|
|
|
Non-current liabilities:
|
|||
|
Non-current debt due after one year
|
|
|
|
|
Other non-current liabilities
|
|
|
|
|
Total liabilities
|
$
|
$
|
|
Foreign
Currency
Translation
|
Cash Flow
Hedges
|
Defined Benefit
Pension and
Postretirement
Plans
|
Other Reserves
(1)
|
Total
(2)
|
|
|
Balance at December 31, 2023
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive loss (income)
|
|
|
(
|
|
|
|
Balance at March 31, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Balance at December 31, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive (income) loss
|
(
|
(
|
|
|
(
|
|
Balance at March 31, 2025
|
$
|
$
|
$
|
$
(
|
$
|
|
Three months ended March 31,
|
|||||||
|
2025
|
2024
|
||||||
|
Pre-Tax
|
Tax
|
Net of
Tax
|
Pre-Tax
|
Tax
|
Net of
Tax
|
||
|
Foreign currency translation gain (loss)
|
$
|
$
|
$
|
$
(
|
$
|
$
(
|
|
|
Defined benefit pension and other post-retirement benefit plans:
|
|||||||
|
Net actuarial loss arising during period
|
|
|
|
(
|
|
(
|
|
|
Amortization and settlement recognition of net actuarial loss
|
|
|
|
|
(
|
|
|
|
Amortization of prior service credit
|
(
|
|
(
|
|
|
|
|
|
Foreign currency (loss) gain - pensions
|
(
|
|
(
|
|
|
|
|
|
Derivatives:
|
|||||||
|
Changes in fair value of cash flow hedges
|
|
|
|
(
|
|
(
|
|
|
Consolidated other comprehensive income (loss)
|
|
|
|
(
|
(
|
(
|
|
|
Less: Other comprehensive (income) loss attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) attributable to common shareholders
|
$
|
$
|
$
|
$
(
|
$
(
|
$
(
|
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Net sales
|
$
7,656
|
$
2,930
|
|
|
Cost of goods sold
|
(6,079)
|
(2,220)
|
|
|
Gross profit
|
1,577
|
710
|
|
|
Selling, general and administrative expenses
|
(988)
|
(380)
|
|
|
Transaction and integration-related expenses associated with the Combination
|
(36)
|
(23)
|
|
|
Operating profit
|
553
|
307
|
|
|
Pension and other postretirement non-service income (expense), net
|
9
|
(10)
|
|
|
Interest expense, net
|
(167)
|
(25)
|
|
|
Other expense, net
|
(5)
|
(5)
|
|
|
Income before income taxes
|
390
|
267
|
|
|
Income tax expense
|
(8)
|
(76)
|
|
|
Net income
|
382
|
191
|
|
|
Net loss attributable to noncontrolling interests
|
2
|
—
|
|
|
Net income attributable to common shareholders
|
$
384
|
$
191
|
|
|
Three months ended March 31,
|
|||
|
2025
|
2024
|
||
|
Net sales (aggregate):
(1)
|
|||
|
North America
|
$
4,669
|
$
412
|
|
|
Europe, MEA and APAC
|
2,582
|
2,194
|
|
|
LATAM
|
513
|
341
|
|
|
Segment Adjusted EBITDA:
|
|||
|
North America
|
$
785
|
$
59
|
|
|
Europe, MEA and APAC
|
389
|
385
|
|
|
LATAM
|
115
|
54
|
|
|
Three months ended March 31,
|
||
|
($ in millions)
|
||
|
2025
|
2024
|
|
|
Net cash provided by operating activities
|
$
235
|
$
42
|
|
Net cash used for investing activities
|
$
(476)
|
$
(207)
|
|
Net cash provided by financing activities
|
$
151
|
$
—
|
|
Three months ended March 31,
|
|||
|
($ in millions)
|
|||
|
2025
|
2024
|
||
|
Net income
|
$
382
|
$
191
|
|
|
Income tax expense
|
8
|
76
|
|
|
Depreciation, depletion and amortization
|
603
|
148
|
|
|
Transaction and integration-related expenses associated with the Combination
|
36
|
23
|
|
|
Interest expense, net
|
167
|
25
|
|
|
Pension and other postretirement non-service (income) expense, net
|
(9)
|
10
|
|
|
Share-based compensation expense
|
43
|
15
|
|
|
Other expense, net
|
5
|
5
|
|
|
Other adjustments
|
17
|
(18)
|
|
|
Adjusted EBITDA
|
$
1,252
|
$
475
|
|
|
Period
|
Total Number of
Shares Purchased
(1)
|
Average Price Paid
per Share
|
Total Number of
Shares Purchased
as Part of Publicly
Announced
Programs
|
Approximate
Dollar Value of
Shares that May Yet
Be Purchased
Under the Programs
|
|||
|
January 1, 2025 – January 31, 2025
|
—
|
$
—
|
—
|
—
|
|||
|
February 1, 2025 – February 28, 2025
|
217,536
|
54.65
|
—
|
—
|
|||
|
March 1, 2025 – March 31, 2025
|
—
|
—
|
—
|
—
|
|||
|
Total
|
217,536
|
—
|
|
Exhibit
Number
|
Description of Exhibit
|
||
|
3.1
|
|||
|
10.1†
|
|||
|
10.2†
|
|||
|
10.3†
|
|||
|
31.1†
|
|||
|
31.2†
|
|||
|
32†*
|
|||
|
101.INS
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.**
|
||
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema.**
|
||
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase.**
|
||
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Document.**
|
||
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase.**
|
||
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase.**
|
||
|
104
|
Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document.
|
|
Smurfit Westrock plc
|
||
|
Dated:
May 9, 2025
|
/s/ Anthony Smurfit
|
|
|
Name:
|
Anthony Smurfit
|
|
|
Title:
|
President & Group Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
||
|
Smurfit Westrock plc
|
||
|
Dated:
May 9, 2025
|
/s/ Ken Bowles
|
|
|
Name:
|
Ken Bowles
|
|
|
Title:
|
Executive Vice President and Group Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|